Literature DB >> 33587339

Profiling plasma-extracellular vesicle proteins and microRNAs in diabetes onset in middle-aged male participants in the ELSA-Brasil study.

Laureane N Masi1, Paulo A Lotufo2, Frederico M Ferreira3, Alice C Rodrigues4, Tamires D A Serdan1, Talita Souza-Siqueira1, Aécio A Braga5, Magda E G Saldarriaga5, Tatiana C Alba-Loureiro1, Fernanda T Borges1, Diego P Cury6, Mario H Hirata5, Renata Gorjão1, Tania C Pithon-Curi1, Simão A Lottenberg7, Ligia M G Fedeli2, Helder T I Nakaya4, Isabela J M Bensenor2, Rui Curi1,8, Sandro M Hirabara1.   

Abstract

We measured plasma-derived extracellular vesicle (EV) proteins and their microRNA (miRNA) cargos in normoglycemic (NG), glucose intolerant (GI), and newly diagnosed diabetes mellitus (DM) in middle-aged male participants of the Brazilian Longitudinal Study of Adult Health (ELSA-Brazil). Mass spectrometry revealed decreased IGHG-1 and increased ITIH2 protein levels in the GI group compared with that in the NG group and higher serotransferrin in EVs in the DM group than in those in the NG and GI groups. The GI group also showed increased serum ferritin levels, as evaluated by biochemical analysis, compared with those in both groups. Seventeen miRNAs were differentially expressed (DEMiRs) in the plasma EVs of the three groups. DM patients showed upregulation of miR-141-3p and downregulation of miR-324-5p and -376c-3p compared with the NG and GI groups. The DM and GI groups showed increased miR-26b-5p expression compared with that in the NG group. The DM group showed decreased miR-374b-5p levels compared with those in the GI group and higher concentrations than those in the NG group. Thus, three EV proteins and five DEMiR cargos have potential prognostic importance for diabetic complications mainly associated with the immune function and iron status of GI and DM patients.
© 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.

Entities:  

Keywords:  epigenetics; glucose intolerance; hyperglycemia; proteomic

Mesh:

Substances:

Year:  2021        PMID: 33587339      PMCID: PMC7883809          DOI: 10.14814/phy2.14731

Source DB:  PubMed          Journal:  Physiol Rep        ISSN: 2051-817X


  80 in total

1.  Prevalence of body iron excess in the metabolic syndrome.

Authors:  Claudia Bozzini; Domenico Girelli; Oliviero Olivieri; Nicola Martinelli; Antonella Bassi; Giovanna De Matteis; Ilaria Tenuti; Valentina Lotto; Simonetta Friso; Francesca Pizzolo; Roberto Corrocher
Journal:  Diabetes Care       Date:  2005-08       Impact factor: 19.112

2.  [Logistics of collection and transportation of biological samples and the organization of the central laboratory in the ELSA-Brasil].

Authors:  Ligia G Fedeli; Pedro G Vidigal; Claudia Mendes Leite; Cristina D Castilhos; Robércia Anjos Pimentel; Viviane C Maniero; Jose Geraldo Mill; Paulo A Lotufo; Alexandre C Pereira; Isabela M Bensenor
Journal:  Rev Saude Publica       Date:  2013-06       Impact factor: 2.106

Review 3.  Proteomics, transcriptomics and lipidomics of exosomes and ectosomes.

Authors:  Dong-Sic Choi; Dae-Kyum Kim; Yoon-Keun Kim; Yong Song Gho
Journal:  Proteomics       Date:  2013-03-12       Impact factor: 3.984

4.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

5.  Association of serum ferritin levels with metabolic syndrome and insulin resistance in a Chinese population.

Authors:  Ling Chen; Yufeng Li; Fang Zhang; Simin Zhang; Xianghai Zhou; Linong Ji
Journal:  J Diabetes Complications       Date:  2016-06-23       Impact factor: 2.852

6.  MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.

Authors:  Dwi Setyowati Karolina; Arunmozhiarasi Armugam; Subramaniam Tavintharan; Michael T K Wong; Su Chi Lim; Chee Fang Sum; Kandiah Jeyaseelan
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

7.  Serum microRNAs as potential biomarkers of primary biliary cirrhosis.

Authors:  Youwen Tan; Tengli Pan; Yun Ye; Guohong Ge; Li Chen; Danfeng Wen; Shengqiang Zou
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

Review 8.  Exosomes: biogenesis, biologic function and clinical potential.

Authors:  Yuan Zhang; Yunfeng Liu; Haiying Liu; Wai Ho Tang
Journal:  Cell Biosci       Date:  2019-02-15       Impact factor: 7.133

9.  Mitochondria-related miR-141-3p contributes to mitochondrial dysfunction in HFD-induced obesity by inhibiting PTEN.

Authors:  Juan Ji; Yufeng Qin; Jing Ren; Chuncheng Lu; Rong Wang; Xiuliang Dai; Ran Zhou; Zhenyao Huang; Miaofei Xu; Minjian Chen; Wei Wu; Ling Song; Hongbing Shen; Zhibin Hu; Dengshun Miao; Yankai Xia; Xinru Wang
Journal:  Sci Rep       Date:  2015-11-09       Impact factor: 4.379

10.  Development of Diagnostic Biomarkers for Detecting Diabetic Retinopathy at Early Stages Using Quantitative Proteomics.

Authors:  Jonghwa Jin; Hophil Min; Sang Jin Kim; Sohee Oh; Kyunggon Kim; Hyeong Gon Yu; Taesung Park; Youngsoo Kim
Journal:  J Diabetes Res       Date:  2015-11-09       Impact factor: 4.011

View more
  5 in total

1.  DIA-Based Proteomic Analysis of Plasma Protein Profiles in Patients with Severe Acute Pancreatitis.

Authors:  He Li; Yansong Xu; Xin Zhou; Taiyang Jin; Ziru Wang; Yuansong Sun; Haiping Wang; Datong Jiang; Chunlin Yin; Bing Shen; Kai Song
Journal:  Molecules       Date:  2022-06-17       Impact factor: 4.927

Review 2.  Diagnostic and Therapeutic Roles of Extracellular Vesicles in Aging-Related Diseases.

Authors:  Zixuan Sun; Xiaomei Hou; Jiaxin Zhang; Jiali Li; Peipei Wu; Lirong Yan; Hui Qian
Journal:  Oxid Med Cell Longev       Date:  2022-08-08       Impact factor: 7.310

Review 3.  Extracellular vesicles-incorporated microRNA signature as biomarker and diagnosis of prediabetes state and its complications.

Authors:  Nicoleta Alexandru; Anastasia Procopciuc; Alexandra Vîlcu; Ioana Karla Comariţa; Elisabeta Bӑdilӑ; Adriana Georgescu
Journal:  Rev Endocr Metab Disord       Date:  2021-06-18       Impact factor: 6.514

Review 4.  Impact of the Main Cardiovascular Risk Factors on Plasma Extracellular Vesicles and Their Influence on the Heart's Vulnerability to Ischemia-Reperfusion Injury.

Authors:  Miłosz Majka; Marcin Kleibert; Małgorzata Wojciechowska
Journal:  Cells       Date:  2021-11-27       Impact factor: 6.600

Review 5.  Akt: A Potential Drug Target for Metabolic Syndrome.

Authors:  Runyu Miao; Xinyi Fang; Jiahua Wei; Haoran Wu; Xinmiao Wang; Jiaxing Tian
Journal:  Front Physiol       Date:  2022-03-07       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.